Page last updated: 2024-08-17

folic acid and Neuroendocrine Tumors

folic acid has been researched along with Neuroendocrine Tumors in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christoph, DC; Hager, T; Mairinger, FD; Schmid, KW; Vollbrecht, C; Walter, RF; Werner, R; Wohlschlaeger, J1
Bhargava, P; Casey, C; Chan, JA; Clark, JW; Earle, CC; Kulke, MH; Regan, E; Stuart, K; Zhu, AX1

Trials

1 trial(s) available for folic acid and Neuroendocrine Tumors

ArticleYear
Phase II study of pemetrexed in patients with advanced neuroendocrine tumors.
    Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:5

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Dexamethasone; Female; Folic Acid; Glutamates; Guanine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Pemetrexed; Survival; Treatment Outcome; Vitamin B 12; Vitamin B Complex

2010

Other Studies

1 other study(ies) available for folic acid and Neuroendocrine Tumors

ArticleYear
Folic-acid metabolism and DNA-repair phenotypes differ between neuroendocrine lung tumors and associate with aggressive subtypes, therapy resistance and outcome.
    Oncotarget, 2016, Apr-12, Volume: 7, Issue:15

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Large Cell; DNA Repair Enzymes; Drug Resistance, Neoplasm; Female; Folate Receptor 1; Folic Acid; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Prognosis; Small Cell Lung Carcinoma; Survival Rate; Young Adult

2016